Humoral immune deficiencyHumoral immune deficiencies are conditions which cause impairment of humoral immunity, which can lead to immunodeficiency. It can be mediated by insufficient number or function of B cells, the plasma cells they differentiate into, or the antibody secreted by the plasma cells. The most common such immunodeficiency is inherited selective IgA deficiency, occurring between 1 in 100 and 1 in 1000 persons, depending on population. They are associated with increased vulnerability to infection, but can be difficult to detect (or asymptomatic) in the absence of infection.
Progenitor cellA progenitor cell is a biological cell that can differentiate into a specific cell type. Stem cells and progenitor cells have this ability in common. However, stem cells are less specified than progenitor cells. Progenitor cells can only differentiate into their "target" cell type. The most important difference between stem cells and progenitor cells is that stem cells can replicate indefinitely, whereas progenitor cells can divide only a limited number of times. Controversy about the exact definition remains and the concept is still evolving.
Maladie immunitaireLes maladies immunitaires, ou immunopathies, regroupent toutes les maladies affectant le système immunitaire. On en distingue deux groupes : les maladies auto-immunes dites « autoinflammatoires » ; les déficits immunitaires, éventuellement d'origine génétique, ou « médiées ». Certaines maladies présentent toutefois des caractéristiques évoquant ces deux types de maladies ( cystite interstitielle, neuromyotonie, sclérodermie, vitiligo, vulvodynie, maladie de Behçet, maladie de Lyme, syndrome des poumons rétractés, maladie de Menière.
HybridomeUn hybridome est une cellule provenant de l'hybridation artificielle de cellules lymphoïdes normales de mammifères et de cellules myélomateuses de tumeurs malignes du système immunitaire. L' hybridome cumule les propriétés des deux cellules de départ : production spécifique d'anticorps pour le lymphocyte et immortalité pour la cellule cancéreuse. Les hybridomes donnent des lignées immortalisées stables productrices d'anticorps monoclonaux.